◆ 会议时间:2025年9月17-20日
◆ 会议简介: 2025年第27届欧洲临床病毒学会(ESCV)年会将于2025年9月17-20日在希腊塞萨洛尼基举行。ESCV年度大会将提供一个出色的科学计划,内容涵盖临床病毒学的最新发现和创新,以及病毒学家感兴趣的当前领域的最新进展。会议将包括在病毒学、肝炎、新出现的病毒和人畜共患病、妊娠期病毒感染以及在一系列病毒性疾病的诊断、监测、预防和治疗方面的下一代测序的应用。 欧洲临床病毒学会(ESCV)是一个非营利性组织,由欧洲快速病毒诊断小组(EGRVD)和欧洲抗病毒病学会(ESAVD)于1997年合并而来。ESCV的宗旨是为所有对临床病毒学和人类病毒疾病的所有方面感兴趣的病毒学家、科学家和医生提供了一个交流的平台;促进公共卫生,宣推进临床和基础病毒学方面的教育,特别是医学教育;提高对病毒的认识,特别是与病毒性疾病的诊断和管理、发病机制、自然史和预防有关的知识;提高诊断方法;通过促进质量评估活动和教育,保持和改进实验室病毒诊断的高标准;与相关组织,如世界卫生组织(WHO)、其他官方组织、其他病毒学协会和团体以及成员之间进行互动;等等。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com) ESCV 2025 – 27th Annual Conference of the European Society for Clinical VirologyDate: 17-20 September, 2025
摘要征文投稿: Call for Abstracts We are pleased to welcome abstracts for the following presentation types: Oral Presentations and Posters. Deadline for abstract submission: 12th May 2025. Online Submission Portal Sign in or create an account with Oxford Abstracts. Use the link to access the submission form 点此提交摘要>>>https://app.oxfordabstracts.com/stages/77236/submitter. Note that event organizers will use this email to communicate with you about the meeting and your abstract submission.
Access the submission form https://app.oxfordabstracts.com/stages/77236/submitter after signing in. As the submitter, you will be asked to fill out the following form fields. Responses to all questions are required (*). Where there are word limits, you are responsible for remaining within the guidelines. Please proofread your abstract carefully as reviewers cannot edit your abstract. Title *
Presentation type *
Authors and affiliations *
Abstract *
Topics *
All author approval *
Permission to publish * Pressing submit:
Modification of submission. You will be able to modify your abstract after submission until the deadline of 12th May 2025. Review of submissions will begin after that date. Multiple submissions. If you wish to submit more than one abstract, please complete a separate form for each. Presenters may be limited in the number of oral presentations that may be accommodated due to scheduling. Submission withdrawal. If you wish to withdraw your abstract, please contact abstracts@escv2025.org. Review Process and Notification Each abstract will be reviewed by members of the scientific committee experts in their field. Abstracts that are incomplete (i.e., not all * questions have been answered) at the time of assignment to reviewers will not be considered for presentation at the meeting. The Scientific Committee will endeavor to schedule abstracts according to authors’ preferences but reserves the right to decide on the final form of presentation. Reviewers are unable to make any changes to your abstract, so please proofread your abstract carefully. The submitter will be notified by email regarding the outcome of their submission once the review process is over. If your abstract is accepted, the presenter is expected to attend and register for ESCV 2025 Annual Meeting by the communicated registration deadline and present the poster or oral presentation. Instructions for oral & poster will be announced after the review process is over.
Welcome to the 27th ESCV ConferenceDear Colleagues and friends, It is our great pleasure to invite you to the 27th ESCV Annual Meeting, to be held in Thessaloniki, Greece, 17-20 September, 2025. The ESCV Annual Meeting has always been a major event for the Clinical Virology scientific community and it is now becoming even more popular, comprehensive, innovative and influential, while maintaining high standards of scientific quality and a family atmosphere. The 27th ESCV Annual Meeting is promising to be an exciting event, covering all timely topics of Clinical Virology, enabling delegates to exchange knowledge with world-class experts, network with colleagues and vividly discuss the latest advances on “traditional” and emerging viruses with the global Virology community. The ESCV 2025 Scientific Committee is preparing a scientific programme of the highest calibre for this event. The Conference will include all of its “classical” features, such as keynote lectures, oral presentations, poster sessions as well as podcasts with cutting-edge virology leaders and prestigious scientific awards to outstanding clinical virologists. Furthermore, state-of-theart diagnostic applications from leading companies on Clinical Virology with high impact on clinical specialties such as Infectious disease specialists, Pediatricians, ICU doctors, Immunologists, Public Health experts, etc, are expected to be presented in industry-sponsored symposia. We firmly believe that Thessaloniki, the second largest city in Greece, is a great asset and a key factor for a successful Congress. Being at a crossroads joining Europe and Asia to the east, and the Balkans with Central and Northern Europe to the north, Thessaloniki is a multi-cultural metropolis, in which one can reach monuments representing 2,300 years of history within a few minutes’ walk. It is by no chance that fifteen of these monuments are listed at the UNESCO World Heritage Sites. Named after Great Alexanders’ sister, the city of Thessaloniki provides a waterfront along Thermaikos Gulf of about 5 Km that residents and visitors can enjoy alike. The city offers excellent conference facilities and outstanding hospitality. Our venue, the Thessaloniki Concert Hall, is located in this vibrant esplanade, in a walking distance from the city center and constitutes an ideal environment for both the dissemination of scientific knowledge and for stimulating social interactions. With that in mind, we look forward to welcoming you to Thessaloniki in September 2025, eager to exchange views on our field and ready to enjoy the marvelous late Greek summer overlooking the Aegean coastline. George Sourvinos Pamela J. Vallely
注册费:
|
,
© 版权声明
本文由分享者转载或发布,内容仅供学习和交流,版权归原文作者所有。如有侵权,请留言联系更正或删除。
相关文章
暂无评论...